Pharma Veterans

Doctors & Pharma Industry – Part 2 of 2 – Asrar Qureshi’s Blog Post 1218 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1218 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: cottonbro studio Preamble Few relationships in modern healthcare are as debated, or as misunderstood, as that between pharmaceutical companies and doctors. To critics, it is a story of undue influence, conflicts of interest, and distorted prescribing. To defenders, it is a necessary partnership that enables medical innovation, education, and patient access to life-saving therapies. The truth lies in between. Code of Conduct – Pharma Companies Pharmaceutical companies play a critical role in safeguarding public health by discovering, manufacturing, and supplying medicines. In Pakistan, where healthcare resources are constrained and patien...

Doctors & Pharma Industry – Part 1 of 2 – Asrar Qureshi’s Blog Post 1217 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1217 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Thirdman Preamble Few relationships in modern healthcare are as debated—or as misunderstood—as that between pharmaceutical companies and doctors. To critics, it is a story of undue influence, conflicts of interest, and distorted prescribing. To defenders, it is a necessary partnership that enables medical innovation, education, and patient access to life-saving therapies. The truth lies in between. Pharma Companies and Doctors –  A Relationship of Necessity, Value, and Risk The relationship between pharma and physicians is structurally unavoidable in a system where: • Drug development is complex and expensive • Clinical knowledg...

Organizational Wellbeing – A New Look – Asrar Qureshi’s Blog #Post 1216 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1216 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Hillary Fox Preamble This blog post is based on an INSEAD KNOWLEDGE article. Link at the end. Rethinking Organizational Well-Being: From Perks to Performance Foundation In recent years, concepts like “well-being at work” have proliferated in corporate discourse. We’ve seen yoga rooms, meditation breaks, gym memberships and digital wellness tools positioned as competitive perks to recruit and retain talent. But growing evidence shows that such superficial initiatives, often treated as human resource frills, are not delivering meaningful impact and are being cut during cost rationalization cycles. Instead of being viewed as an add-on, well-bei...

Pharmaceutical Distribution Systems – A Strategic Opportunity – Asrar Qureshi’s Blog Post #1215 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1215 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Antonius Natan Credit: Lidia Volovaci Preamble This blog post is based on insights from a McKinsey article. Link at the end. From Warehouse to Wellness: What Modern Pharmaceutical Distribution Means for Pakistan For decades, pharmaceutical distribution in Pakistan has been viewed largely as a logistics function, warehouses, trucks, stockists, and retailers moving cartons of medicines across cities and districts. Yet, as global healthcare systems evolve toward specialty medicines, biologics, and patient-centric care, this traditional view is becoming dangerously outdated. Insights from McKinsey’s discussion with Bob Ma...

Implications of US Withdrawal from World Bodies – Asrar Qureshi’s Blog Post #1214 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1214 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Safi Erneste Preamble This blog post is based on an article written by Lydia Gichuki for DevelopmentAid Digest.. Link at the end. When a Superpower Steps Back: How the U.S. Exit from 66 Global Bodies Is Rewriting the World System In early January 2026, the United States government made a move with seismic implications for international cooperation: President Donald J. Trump signed a presidential memorandum directing the withdrawal of the U.S. from 66 international organizations, a sweeping disengagement that spans United Nations bodies and non-UN multilateral institutions. This move marks far more than a policy shift. It heralds a ...

Team Size – Gallup Report – Asrar Qureshi’s Blog Post #1213 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1213 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Matheus Bertelli Credit: Yusuf Çelik Preamble This blog post is based on a recent Gallup® report. Link at the end. Why Team Size Matters: Insights from Gallup on Optimal Span of Control for Managers In today’s rapidly evolving workplace, organizations are constantly asking: How many people should report to a manager? While the question seems straightforward, the answer is far from simple. According to new Gallup research, the “span of control” – the number of direct reports a manager oversees – has significant implications for organizational performance, employee engagement, leadership effectiveness, and overall workplace health. Gallup’s analysis revea...

Top Risks for 2026 Part 3 – Eurasia Group Report – Asrar Qureshi’s Blog Post #1212 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1212 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Afitab Credit: Ahmed Aziz Credit: Tima Miroshnichenko Preamble This 3-part blog post is based on a Eurasia Group report titled ‘Top Risks for 2026’. Link at the end. About Eurasia Group. [Quote]. Today's geopolitical environment is increasingly complex, with risks coming at an accelerated pace as the world order undergoes significant change.  It has never been more important for business decision-makers and investors to incorporate political risk into their strategies to spot the opportunities and manage the risks that politics creates—and to lead their organizations through turbulent times. Eurasia Group's advisory and consu...

Top Risks for 2026 Part 2 – Eurasia Group Report – Asrar Qureshi’s Blog Post #1211 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1211 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Kelly Credit: Wolfgang Weiser Preamble This 3-part blog post is based on a Eurasia Group report titled ‘Top Risks for 2026’. Link at the end. About Eurasia Group. [Quote]. Today's geopolitical environment is increasingly complex, with risks coming at an accelerated pace as the world order undergoes significant change.  It has never been more important for business decision-makers and investors to incorporate political risk into their strategies to spot the opportunities and manage the risks that politics creates—and to lead their organizations through turbulent times. Eurasia Group's advisory and consulting business is built ...

Top Risks for 2026 - Part 1 – Eurasia Group Report – Asrar Qureshi’s Blog Post #1210 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1210 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Google Images Credit: Google Images Preamble This 3-part blog post is based on a Eurasia Group report titled ‘Top Risks for 2026’. Link at the end. About Eurasia Group. [Quote]. Today's geopolitical environment is increasingly complex, with risks coming at an accelerated pace as the world order undergoes significant change.  It has never been more important for business decision-makers and investors to incorporate political risk into their strategies to spot the opportunities and manage the risks that politics creates—and to lead their organizations through turbulent times. Eurasia Group's advisory and consulting business i...